These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27043768)

  • 1. Fluorocoxib A loaded nanoparticles enable targeted visualization of cyclooxygenase-2 in inflammation and cancer.
    Uddin MJ; Werfel TA; Crews BC; Gupta MK; Kavanaugh TE; Kingsley PJ; Boyd K; Marnett LJ; Duvall CL
    Biomaterials; 2016 Jun; 92():71-80. PubMed ID: 27043768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Pluoronic nanoparticles of fluorocoxib A for endoscopic fluorescence imaging of colonic adenomas.
    Uddin MJ; Niitsu H; Coffey RJ; Marnett LJ
    J Biomed Opt; 2023 Apr; 28(4):040501. PubMed ID: 37091910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose safety and pharmacokinetic evaluation of fluorocoxib A: pilot study of novel cyclooxygenase-2-targeted optical imaging agent in a canine model.
    Cekanova M; Uddin MJ; Legendre AM; Galyon G; Bartges JW; Callens A; Martin-Jimenez T; Marnett LJ
    J Biomed Opt; 2012 Nov; 17(11):116002. PubMed ID: 23117797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging of cyclooxygenase-2 in canine transitional cell carcinomas in vitro and in vivo.
    Cekanova M; Uddin MJ; Bartges JW; Callens A; Legendre AM; Rathore K; Wright L; Carter A; Marnett LJ
    Cancer Prev Res (Phila); 2013 May; 6(5):466-76. PubMed ID: 23531445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted imaging of cancer by fluorocoxib C, a near-infrared cyclooxygenase-2 probe.
    Uddin MJ; Crews BC; Ghebreselasie K; Daniel CK; Kingsley PJ; Xu S; Marnett LJ
    J Biomed Opt; 2015 May; 20(5):50502. PubMed ID: 25970082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trifluoromethyl fluorocoxib a detects cyclooxygenase-2 expression in inflammatory tissues and human tumor xenografts.
    Uddin MJ; Crews BC; Huda I; Ghebreselasie K; Daniel CK; Marnett LJ
    ACS Med Chem Lett; 2014 Apr; 5(4):446-50. PubMed ID: 24900856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of carcinogen-induced bladder cancer by fluorocoxib A.
    Bourn J; Rathore K; Donnell R; White W; Uddin MJ; Marnett L; Cekanova M
    BMC Cancer; 2019 Nov; 19(1):1152. PubMed ID: 31775672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric Micellar Nanoparticles Enable Image-guided Drug Delivery in Solid Tumors.
    Uddin J; Oltman CG; Lo JH; Gupta MK; Werfel TA; Mohyuddin M; Nazmin F; Rahman S; Crews BC; Kingsley PJ; Marnett LJ; Duvall CL; Cook RS
    bioRxiv; 2024 Jun; ():. PubMed ID: 38915607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents.
    Uddin MJ; Crews BC; Blobaum AL; Kingsley PJ; Gorden DL; McIntyre JO; Matrisian LM; Subbaramaiah K; Dannenberg AJ; Piston DW; Marnett LJ
    Cancer Res; 2010 May; 70(9):3618-27. PubMed ID: 20430759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorocoxib A enables targeted detection of cyclooxygenase-2 in laser-induced choroidal neovascularization.
    Uddin MJ; Moore CE; Crews BC; Daniel CK; Ghebreselasie K; McIntyre JO; Marnett LJ; Jayagopal A
    J Biomed Opt; 2016 Sep; 21(9):90503. PubMed ID: 27626899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of non-melanoma skin cancer by in vivo fluorescence imaging with fluorocoxib A.
    Ra H; González-González E; Uddin MJ; King BL; Lee A; Ali-Khan I; Marnett LJ; Tang JY; Contag CH
    Neoplasia; 2015 Feb; 17(2):201-7. PubMed ID: 25748239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smart IR780 Theranostic Nanocarrier for Tumor-Specific Therapy: Hyperthermia-Mediated Bubble-Generating and Folate-Targeted Liposomes.
    Guo F; Yu M; Wang J; Tan F; Li N
    ACS Appl Mater Interfaces; 2015 Sep; 7(37):20556-67. PubMed ID: 26322900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release.
    Li Y; Wu H; Yang X; Jia M; Li Y; Huang Y; Lin J; Wu S; Hou Z
    Mol Pharm; 2014 Aug; 11(8):2915-27. PubMed ID: 24984984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
    Huang Y; Mao K; Zhang B; Zhao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of DOX bioavailability in biological samples of mice by sensitive and precise HPLC assay.
    Zhang C; Wu Y; Dong Y; Xu H; Zhao L
    Pharm Biol; 2016; 54(1):55-61. PubMed ID: 25880143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time near-infrared fluorescence imaging using cRGD-ZW800-1 for intraoperative visualization of multiple cancer types.
    Handgraaf HJM; Boonstra MC; Prevoo HAJM; Kuil J; Bordo MW; Boogerd LSF; Sibinga Mulder BG; Sier CFM; Vinkenburg-van Slooten ML; Valentijn ARPM; Burggraaf J; van de Velde CJH; Frangioni JV; Vahrmeijer AL
    Oncotarget; 2017 Mar; 8(13):21054-21066. PubMed ID: 28416744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma.
    Lupi M; Colombo C; Frapolli R; Ferrari R; Sitia L; Dragoni L; Bello E; Licandro SA; Falcetta F; Ubezio P; Bigini P; Salmona M; D'Incalci M; Morbidelli M; Moscatelli D
    Nanotechnology; 2014 Aug; 25(33):335706. PubMed ID: 25074670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical imaging of COX-2: studies on an autofluorescent 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitor.
    Tondera C; Ullm S; Laube M; Meister S; Neuber C; Mosch B; Kniess T; Pietzsch J
    Biochem Biophys Res Commun; 2015 Feb; 458(1):40-5. PubMed ID: 25637530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic characterization of fluorocoxib D, a cyclooxygenase-2-targeted optical imaging agent for detection of cancer.
    Cekanova M; Pandey S; Olin S; Ryan P; Stokes JE; Hecht S; Martin-Jimenez T; Uddin MJ; Marnett LJ
    J Biomed Opt; 2020 Aug; 25(8):. PubMed ID: 32860356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.